"Sometimes stocks deserve to go up on nothing, but it still seems a little quizzical to see stocks levitate like they’re doing here," the "Mad Money" host said.
"The intent is really to be able to decentralize PCR testing and make it available to anyone who needs to get tested," medical device maker Visby CEO Adam de La Zerda told CNBC's Jim Cramer.
"The reality is it's just more expensive to operate, you know, in the coronavirus world that we're living in now," Domino's Pizza CEO Ritch Allison told CNBC's Jim Cramer.
"Main Street may indeed need a stimulus deal, but Wall Street can do just fine without one, and so can your portfolio as long as you focus on the bull markets that don't need no stinking bailout," the "Mad Money" host said.
"MyoKardia is an important company because they developed a really interesting approach to the treatment of cardiovascular disease," Bristol-Myers Squibb CEO Giovanni Caforio said.